Eli Lilly and Company (NYSE:LLY) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 14, Reuters reported that Eli Lilly and Company (NYSE:LLY) has entered into a deal worth $1 ...

For savvy investors looking for long-term businesses that not only dominate their industries today but also have the ...

Wall Street braced for results from retail giants as rising concerns over inflation cloud the path to an interest rate cut.

A group of vaccine-skeptical doctors and mandate opponents is challenging the CDC’s childhood immunization schedule in ...

ORLANDO, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Endocrinology Drugs Market during the forecasted period 2025-2032 The ...

Worldwide, 3·9 million individuals have kidney failure requiring maintenance dialysis.1,2 Considerable resources—more than 7% ...

Also in today’s newsletter, Qantas hit with record fine over Covid job cuts, and Citi’s raid on JPMorgan investment bankers ...

According to a new comprehensive report from The Insight Partners, the global cancer drugs market is witnessing substantial growth with the growing breast ...

The markets once again had a strong week, with all three indexes posting strong gains last week. This came amid a mixed bag of economic reports. As I mentioned in last Friday’s Market 360, the CPI ...

Ball State University has launched its 2025-30 strategic plan that was approved in June. The plan has a long list of goals, including: •All students complete at least one course that involves ...

Investing.com -- Novo Nordisk and Eli Lilly (NYSE: LLY) shares edged higher Tuesday following results from Viking Therapeutics’ Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo ...

Shares of Eli Lilly (LLY) are up $11.11, or about 2%, to $709.29 in pre-market trading while those of Novo Nordisk (NVO) trading in New York are ...